By Aidan Sowa, CEO and Founder, Frontier Industries | October 2026
Food used to be marketed on taste and price. Your category is now marketed on claims, and claims are where nutrition brands live or get litigated. Every package you ship makes promises a regulator grades, a plaintiff's firm collects, and a sceptical public increasingly fact checks at the shelf. This guide sets one standard for your agency: can this team navigate the claims ladder, from authorised health claims down to a single influencer caption, without letting a sentence outrun its evidence file. In nutrition, that discipline is not compliance overhead. It is the brand.
| Measure | Figure | Source |
|---|---|---|
| Adults who trust food and beverage companies to act in their interest | 25 percent | KFF Health Tracking Poll, 2026 |
| Adults saying food additives are not regulated enough | 75 percent | KFF Health Tracking Poll, 2026 |
| Advertisers put on FTC notice over unsubstantiated claims | About 670 companies | FTC, reported 2023 |
I. Discrimen
A food claim is a legal instrument wearing a headline's clothes
Nutrition claims come in a formal hierarchy that most marketing ignores. Authorised health claims link a substance to a disease and require FDA authorisation backed by significant scientific agreement. Qualified health claims rest on credible but weaker evidence and must carry disclaimers reflecting that. Structure and function claims describe a nutrient's normal role in the body and follow yet another rule set, with different treatment for foods and supplements (Revision Legal summary of the FDA and FTC framework). Each rung has its own evidence price.
Your agency's literacy test is whether it can sort your current claims onto the right rungs and tell you which ones are standing on a rung that does not exist. Brands get in trouble in the gaps: a structure and function sentence styled like a disease promise, a qualified claim printed without its qualifier, an implied claim built from imagery and product naming that no one wrote down and everyone approved.
Nobody sues you over the claim you wrote carefully. They sue over the one your packaging implied at a glance.
Product naming is the most common unexamined claim in the category. A name can imply a disease benefit, a nutrient content level or a clinical result before a single sentence is read, and both regulators and courts treat the total impression as the claim. Add the visual layer: the athlete, the stethoscope, the before and after photograph, the heart shaped badge your designer borrowed from a certification you do not hold. Your agency's audit has to cover names, marks, imagery and colour semiotics, not just copy decks, because that is where the implied claims live and where competitors' complaint letters to retailers usually aim.
II. Machina
Two agencies split your sentence between them, and both collect files
The machinery is divided on purpose. The FDA governs what your label says. The FTC governs what your advertising says everywhere else: web, social, television, packaging adjacent promotion. The FTC standard requires claims to be substantiated before publication with competent and reliable scientific evidence, and for claims that a product cures, mitigates or treats a serious disease, at least one well controlled human clinical trial (FTC notice of penalty offences, reported 2023). The landmark POM Wonderful case established that disease claims demand randomised controlled trial evidence, a standard the industry has operated under since (FTC v. POM Wonderful, as summarised in Revision Legal's claims guide).
In 2023 the FTC put roughly 670 marketers of drugs, supplements, homeopathics and functional foods on penalty notice, making future violations worth up to 50,120 dollars each (Manatt, 2023). Your agency should be able to recite this landscape from memory, because your creative will be graded against it by people who definitely can.
Your label answers to one referee and your Instagram to another. Hire people who have met both.
III. Exemplum
POM Wonderful bought the industry its most expensive lesson
The pomegranate juice maker marketed its product with claims about heart disease, prostate cancer and erectile dysfunction, backed by studies the FTC found inadequate for claims of that weight. The resulting litigation ran for years, produced a D.C. Circuit ruling that the FTC could require at least one randomised controlled trial for disease claims, and left the company with its marketing permanently narrowed (FTC v. POM Wonderful, summarised in Revision Legal). The brand had real research. It did not have research at the level its sentences claimed.
Set that beside the quieter winners in your category: brands that built equity on sourcing, farming practice, taste and transparently modest claims, and were still standing, unembarrassed, when the enforcement weather changed. The lesson for agency selection is direct. Ask candidates to show you a claim they weakened for a client and what it cost commercially. Teams that have never paid that price cannot be trusted to charge it to you when necessary.
A claim is a loan against your evidence. POM Wonderful shows the foreclosure process.
IV. Damnum
The trust environment now taxes every sentence you print
Your audience starts from suspicion, and it is not your fault. KFF's April 2026 tracking poll found only 25 percent of adults trusting food and beverage companies to act in the public's best interest, 21 percent trusting pharmaceutical companies, and about a third expressing confidence that the FDA acts independently (KFF, 2026). Three quarters of adults said chemical food additives are not regulated enough, a majority that holds across party lines (KFF, 2026). In other words, your customers doubt you, doubt your referee, and want more rules, simultaneously.
Translate that into communications economics. Every claim you publish pays a scepticism surcharge: it must arrive with its evidence closer to the surface than your competitors bother with, or it gets discounted to zero. The cost of a public claims failure is correspondingly higher, because it confirms the majority's standing theory about your industry. An agency that prices campaigns without pricing this environment is working from a 2015 map.
When three quarters of your market thinks your industry is under regulated, modesty is not caution. It is positioning.
V. Genus
The variable that separates surviving brands is claim to evidence distance
Measure any nutrition brand by one ratio: the strength of its loudest claim divided by the strength of its best study. Brands that keep the ratio near one survive enforcement cycles, retailer audits and media investigations. Brands running at three or four eventually meet a regulator, a class action, or a journalist with time. The FTC also polices the space around the claim: misrepresenting the level of substantiation, or describing a product as clinically proven without the trials to match, are listed offences in their own right (ECJ Law summary of the FTC notices, 2023).
Your agency interview should therefore be an audit exercise. Hand over your packaging and your last campaign. Ask for a distance grade on every claim and a rewrite plan for the outliers. The exercise takes an afternoon and predicts the entire relationship. An agency that grades generously is telling you it will spend your risk budget on its creative awards.
Keep the ratio at one. Growth bought above one is borrowed from your future legal budget.
VI. Regio
Your shelf, your feed and your regulator are three different courtrooms
| Audience | What they are deciding | Evidence standard they apply |
|---|---|---|
| Grocery and retail buyers | Whether your velocity justifies the shelf risk | Sales data, claim cleanliness, recall and litigation history |
| Core consumers | Whether your product belongs in a family kitchen | Ingredient transparency, price fairness, brand behaviour over time |
| Health professionals and dietitians | Whether they can mention you without embarrassment | Study quality, dosage realism, honest limitations |
| Influencers' audiences | Whether a recommendation is an ad or a belief | Disclosure clarity, typicality of results, creator credibility |
| FDA, FTC and state attorneys general | Whether your claims match your files | The formal ladders and standards in sections I and II |
The endorsement layer deserves its own sentence of caution. The FTC's revised Endorsement Guides took effect in 2023 and its Reviews and Testimonials Rule followed in 2024, making brands liable for endorsers' undisclosed connections and unsubstantiated testimonial claims (MarketHealth summary of FTC guidelines, 2024). A dietitian's casual post about your bar is your advertising, with your liability, the moment you pay, gift or brief her.
Every channel grades the same claims with different instruments. Your files have to pass all of them.
Private enforcement deserves a line in your planning too, because in this category it often arrives before the regulators do. Competitors file complaints with advertising self regulatory bodies and retailer compliance teams, and consumer class actions over label claims are a standing feature of the food business. The practical meaning is that your substantiation file is not a defensive archive. It is the document set your agency will need, quickly and in public, when a rival or a plaintiff's firm asks a retailer to justify your shelf presence. Brands that maintain the file as a living system answer in days and keep distribution. Brands that assemble it under deadline discover, expensively, what their claims actually rest on.
VII. Occasio
The reformulation era is the opening, and transparency is the entry fee
Public argument about ultra processed foods, additives and front of pack disclosure is moving from podcasts into policy: 75 percent of adults in KFF's polling want stronger regulation of food additives (KFF, 2026), and the political coalition behind food reform now spans voters who agree on little else. For a nutrition brand, this climate is usually read as threat. Read it instead as a sorting mechanism. When rules tighten, the brands with clean labels, conservative claims and published standards inherit the shelf space and the trust that looser competitors vacate.
Your agency should be building that inheritance now: reformulation stories told before they are forced, ingredient glossaries a parent can parse, packaging changes explained as convictions rather than concessions. The first brand in a category to narrate its own tightening standards becomes the reference point journalists use to grade everyone else.
When the rules tighten, the prepared brand does not scramble. It collects.
VIII. Structura
A small brand with a spotless file outlasts a loud one with a lawyer
Nutrition has near zero barriers to entry and rising barriers to belief, the same inversion as the rest of consumer health, sharpened by retail gatekeeping. A challenger brand that keeps its claims at evidence level, publishes its testing and treats dietitians as auditors rather than influencers can take shelf and trust from incumbents whose marketing was written in a looser era and never re audited. Incumbency, in this category, is often just a larger archive of unexamined sentences.
Choose your agency by the same principle. The boutique that re audits its own past campaigns unprompted is worth more than the famous shop still running claim habits from before the 2023 notices. Ask what their firm changed about its own practice when the penalty notices went out. The answer is a culture test disguised as a history question.
Old copy is a liability with a media budget. Audit it like one.
IX. Consilium
Sequence the work: audit the claims, then build the story they can carry
| Agency option | Fit for a nutrition brand | Principal risk |
|---|---|---|
| Food and beverage specialist agency | Knows the claims ladder, retailers and category press | May normalise the category's bad habits |
| Consumer packaged goods brand agency | Packaging, shelf impact and campaign craft | Claim discipline often trails the design work |
| Regulatory minded health communications firm | Evidence files, professional audiences, enforcement calm | Consumer warmth and cultural timing may lag |
| Creator and social led agency | Feed fluency and community building | Endorsement and typicality violations are endemic risks |
| In house team with external claims counsel and PR support | Tight control of daily claim decisions | Range narrows to the team's own experience |
| Criterion | Weight | Evidence to demand |
|---|---|---|
| Claims ladder literacy | High | Your top claims sorted by category, live, with evidence grades |
| Substantiation file practice | High | A sample claim file, from evidence to approved sentence |
| Endorser governance | High | Briefs, contracts and monitoring for paid health voices |
| Retailer credibility | Medium | Buyer facing materials that survived a category review |
| Professional audience respect | Medium | Dietitian and clinician engagement that was not pay to post |
The other consumer health guidance sits in the resources library, and engagement structures are set out on the public relations services page. Brands with supplements or functional lines should read the companion guide for wellness companies alongside this one, because your portfolio probably answers to both rule sets.
Frequently asked questions
What is the difference between a health claim and a structure and function claim in practice?
A health claim links your product to a disease and needs FDA authorisation or qualification. A structure and function claim describes a nutrient's normal role, like calcium builds strong bones, and follows notification and disclaimer rules that differ between foods and supplements. Your agency should never let the two wear each other's clothes.
Can a customer testimonial say our product lowered her cholesterol?
Not safely. A testimonial that makes a disease claim the brand could not make itself is treated as the brand's claim, and results described must reflect typical outcomes or disclose what is typical. Your agency should be rewriting testimonial use around experience and taste, and leaving disease outcomes to your evidence, if you have any.
Our study is small but real. What can we claim?
Claim at the level of the study: population, dose, duration and endpoint, with qualifiers intact, and consider whether it supports a qualified claim with its required disclaimer. An agency that rounds a pilot study up to a proven benefit is manufacturing your future enforcement problem.
How do we handle influencer partnerships with dietitians?
Written briefs with approved and banned claims, disclosure that is difficult to miss in the format of the post, pre publication review, and payment terms that include correction duties. The FTC has already sent warning letters in exactly this pattern, to associations and the dietitians they hired.
Should we reformulate before regulation forces it?
If the reformulation is coming anyway, telling the story early converts a compliance cost into a positioning asset. Brands that wait get the same bill with none of the credit. Your agency should be sequencing the narrative while your food scientists sequence the recipe.
What belongs in our claim file for each product?
The exact approved sentences per channel, the evidence behind each with study citations, the rung of the claims ladder each occupies, review dates and the names of who approved them. If that file does not exist today, building it is your agency's first deliverable, before any campaign.
Do private label and co manufactured products change our responsibilities?
No. If your name is on the package, the claims are yours, whoever formulated or filled it. Your agency should make sure substantiation files travel with every private label agreement, and that a supplier's marketing enthusiasm never reaches your label without your own evidence review.
How do we respond when a journalist questions an ingredient we use?
With your file open: why it is there, at what level, what the safety literature says, and what you are watching. Brands that answer ingredient questions with data keep the story to one cycle. Brands that answer with indignation get a series.
How this guide was built
This guide draws on the FDA and FTC claims framework as summarised by food and advertising law specialists, FTC penalty notice reporting from 2023, the POM Wonderful litigation record, KFF tracking poll data on food industry trust and regulation, and FTC endorsement policy summaries. Its limits: claim categories turn on your product's exact regulatory status, which differs across foods, beverages and supplements, and state attorneys general add a further enforcement layer that varies by state. Treat the framework here as your agency interview syllabus, and have qualified counsel grade your actual labels before market.
X. Incipe
Where Frontier Industries fits in this decision
Frontier Industries represents health and food brands that expect their claims to be read by regulators, retailers and sceptical families at once. For nutrition brands the practice starts where this guide starts: a full claims audit against the ladder, an evidence file per product, and endorser governance, with storytelling built only on what survives. Meet the team on the about page, and if your range includes care services, the guide for senior care providers covers the households you feed.
Bring your packaging and your boldest current claim to the first meeting. Write through the industry campaign page, or call 401-219-4207 with the claim list in hand.
Sources
1. Revision Legal, Health Claims on Dietary Supplements: Legal Guide, covering FDA claim categories and the FTC substantiation standard. https://revisionlegal.com/corporate/health-claims-dietary-supplements-legal-guide/ 2. Manatt, Phelps and Phillips, FTC Warns Almost 700 Advertisers: Substantiate Your Claims or Face Civil Penalties, 2023. https://www.manatt.com/insights/newsletters/advertising-law/ftc-warns-almost-700-advertisers-substantiate-your 3. Loeb and Loeb, FTC Warns Nearly 700 Health Product Marketers to Avoid Unsubstantiated Claims, 2023. https://www.loeb.com/en/insights/publications/2023/04/ftc-warns-nearly-700-health-product-marketers-to-avoid-unsubstantiated-claims 4. JD Supra, FTC Puts Almost 700 Advertisers on Notice That They May Face Civil Penalties for Unsubstantiated Claims, 2023. https://www.jdsupra.com/post/contentViewerEmbed.aspx?fid=4c480b03-3c1c-453e-9a77-4a4494f6bc37 5. Ervin Cohen and Jessup, FTC Warns Advertisers about Unsubstantiated Product Claims and Endorsements, 2023. https://www.ecjlaw.com/ecj-blog/ftc-warns-advertisers-about-unsubstantiated-product-claims-and-endorsements 6. KFF, KFF Health Tracking Poll: MAHA and the Midterms, April 2026. https://www.kff.org/public-opinion/kff-health-tracking-poll-maha-and-the-midterms/ 7. KFF, KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently, 2026. https://www.kff.org/health-information-trust/kff-poll-finds-that-most-adults-lack-confidence-in-key-health-agencies-to-act-independently/ 8. MarketHealth, New FTC Marketing Guidelines, covering the 2023 Endorsement Guides and the 2024 Reviews and Testimonials Rule. https://markethealth.com/blogs/news/new-ftc-marketing-guidelines 9. Lexology, FTC reminds companies about need for influencer disclosures, 2023. https://www.lexology.com/library/detail.aspx?g=a6b88b3e-867d-4746-b314-456040e46eea 10. FoodChain ID, FTC Guidance on Advertising Claims Update, 2023. https://www.foodchainid.com/resources/united-states-updated-ftc-guidance-on-claims-in-advertising/